Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene

Circulation Research

Volumn 81, Issue 1, 1997, Pages 34-41

  Steudel, Wolfgang ^a   Ichinose, Fumito ^a   Huang, Paul L ^a   Hurford, William E ^a   Jones, Rosemary C ^a   Bevan, John A ^b   Fishman, Mark C ^a   Zapol, Warren M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Acetylcholine; Mouse; Nitric oxide; Pulmonary vascular resistance; Targeted nitric oxide synthase 3 gene disruption

Indexed keywords

GENE PRODUCT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HYPOXIC LUNG VASOCONSTRICTION; LUNG CIRCULATION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0030955626     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.1.34     Document Type: Article

References (33)

1. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem. 1993;268:12231-12234.
2. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther. 1981;219:181-186.
3. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
4. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
5. Shaul PW, North AJ, Wu LC, Wells LB, Brannon TS, Lau KS, Michel T, Margraf LR, Star RA. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest. 1994;94:2231-2236.
6. Celermajer DS, Dollery C, Burch M, Deanfield JE. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. Circulation. 1994;89:2041-2044.
7. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
8. Koizumi T, Gupta R, Banerjee M, Newman JH. Changes in pulmonary vascular tone during exercise: effects of nitric oxide (NO) synthase inhibition, L-arisinine infusion, and NO inhalation. J Clin Invest. 1994;94:2275-2282.
9. Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation. 1995;92:1539-1545.
10. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427-435.
11. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399-405.
12. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
13. Roberts JD Jr, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res. 1995;76:215-222.
14. Cremona G, Wood AM, Hall LW, Bower EA, Higenbottam T. Effects of inhibitor of nitric oxide release on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol (Lond). 1994;481:185-195.
15. Isaacson TC, Hampl V. Weir KE. Nelson DP, Archer SL. Increased cndothelium-derivt'd NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physio!. 1994:76:933-940.
16. Hampl V, Archer SL, Nelson DP, Weir K. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol. 1993;75:1748-1757.
17. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992;262:H1362-H1371.
18. ω-Nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J Appl Physiol. 1991;71: 2026-2031.
19. ω-Nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol. 1991;260:H1299-H1306.
20. Hasunuma K, Yamagushi T, Rodman DM, O'Brien F, McMurty IF. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am J Physiol. 1991;260:L97-L104.
21. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand. 1990;140:449-457.
22. Archer SL, Rist K, Nelson DP, Demaster EG, Cowan N, Weir EK. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol. 1991;68:735-747.
23. Brashers VL, Peach MJ, Rose CE. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest. 1988;82:1495-1502.
24. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene-blue. J Appl Physiol. 1991;71:735-741.
25. Cherry PD, Gillis CN. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilation in the intact lung. J Pharmacol Exp Ther. 1987;241:516-520.
26. Barnard JW, Wilson PS, Moore TM, Thompson WT, Tuylor AE. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J Appl Physiol. 1993;74:2940-2948.
27. Klabunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium-derived releasing factor (nitric oxide) formation/release in anesthetized dogs. Eur J Pharmacol. 1991;199: 51-59.
28. Loeb AL, Longnecker DE. Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am J Physiol. 1992;262:H1494-H1500.
29. Perrella MA, Hildebrand FL, Margulies KB, Burnett JC. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol. 1991;261:R323-R328.
30. Davidge ST, Baker PN, McLaughlin MK, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 1995;77: 274-283.
31. Roos CM, Rich GF, Uncles DR, Daugherty MO, Frank DU. Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs. J Appl Physiol. 1994;77:51-57.
32. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
33. Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.